Compounds > nitrosobis(2-oxopropyl)amine
Page last updated: 2024-08-23

nitrosobis(2-oxopropyl)amine and trelstar

nitrosobis(2-oxopropyl)amine has been researched along with trelstar in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Groot, K; Lapis, K; Schally, AV; Srkalovic, G; Szende, B1
Schally, AV; Zalatnai, A2
Fekete, M; Schally, AV; Zalatnai, A1
Comaru-Schally, AM; Fekete, M; Schally, AV; Zalatnai, A1
Csikós, A; Halmos, G; Lapis, K; Mulchahey, JJ; Neill, JD; Schally, AV; Szende, B; Szepeshazi, K1

Other Studies

6 other study(ies) available for nitrosobis(2-oxopropyl)amine and trelstar

ArticleYear
Regression of nitrosamine-induced pancreatic cancers in hamsters treated with luteinizing hormone-releasing hormone antagonists or agonists.
    Cancer research, 1990, Jun-15, Volume: 50, Issue:12

    Topics: Animals; Antineoplastic Agents; Cricetinae; Female; Gonadotropin-Releasing Hormone; Mesocricetus; Nitrosamines; Pancreatic Neoplasms; Receptors, Cell Surface; Receptors, LH; Receptors, Somatomedin; Remission Induction; Triptorelin Pamoate

1990
Treatment of N-nitrosobis(2-oxopropyl)amine-induced pancreatic cancer in Syrian golden hamsters with D-Trp-6-LH-RH and somatostatin analogue RC-160 microcapsules.
    Cancer research, 1989, Apr-01, Volume: 49, Issue:7

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capsules; Cricetinae; Female; Gonadotropin-Releasing Hormone; Mesocricetus; Neoplasm Metastasis; Nitrosamines; Organ Size; Pancreatic Neoplasms; Somatostatin; Triptorelin Pamoate

1989
Responsiveness of the hamster pancreatic cancer to treatment with microcapsules of D-Trp-6-LH-RH and somatostatin analog RC-160. Histological evidence of improvement.
    International journal of pancreatology : official journal of the International Association of Pancreatology, 1989, Volume: 4, Issue:2

    Topics: Animals; Antineoplastic Agents; Capsules; Cricetinae; Epithelium; Gonadotropin-Releasing Hormone; Male; Mesocricetus; Nitrosamines; Pancreas; Pancreatic Neoplasms; Somatostatin; Triptorelin Pamoate

1989
Presence of membrane binding sites for [D-TRP6]-luteinizing hormone-releasing hormone in experimental pancreatic cancer.
    Cancer letters, 1989, Volume: 45, Issue:2

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cricetinae; ErbB Receptors; Female; Gonadotropin-Releasing Hormone; Mesocricetus; Nitrosamines; Pancreatic Neoplasms; Receptors, LHRH; Receptors, Neurotransmitter; Receptors, Somatostatin; Somatostatin; Triptorelin Pamoate

1989
Membrane receptors for peptides in experimental and human pancreatic cancers.
    Pancreas, 1989, Volume: 4, Issue:5

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Autopsy; Carcinogens; Cricetinae; ErbB Receptors; Female; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Mesocricetus; Nitrosamines; Pancreatic Neoplasms; Receptors, LHRH; Receptors, Somatotropin; Somatostatin; Triptorelin Pamoate

1989
The concentration of LH-RH receptors in the nuclei of pancreatic cancer cells. Effect of (D-Trp6)LH-RH on tumor-bearing Syrian golden hamsters.
    Receptor, 1994,Winter, Volume: 4, Issue:4

    Topics: Animals; Carcinogens; Cell Nucleus; Cricetinae; Female; Immunohistochemistry; Mesocricetus; Microscopy, Immunoelectron; Nitrosamines; Pancreatic Neoplasms; Radioligand Assay; Receptors, LHRH; Triptorelin Pamoate

1994